Friday, July 1

Measure the effectiveness of Pfizer and Astrazeneca against Delta | Digital Trends Spanish

An important study from the University of Oxford revealed the level of effectiveness of the Pfizer and AstraZeneca vaccines against the contagious Delta variant of COVID-19.

The study, published in the journal Cell, looked at the ability of antibodies in the blood of people, who were vaccinated with the two-injection regimens, to neutralize the highly contagious Delta and Kappa variants, according to a statement.

In fact, a few days ago he had settled in Britain for the Public Health England, that the two doses of either of the two vaccines, would help 90% in avoiding hospitalization for Delta.


“We are encouraged to see the non-clinical results published from Oxford and these data, together with the recent early real-world analysis from Public Health England, give us a positive indication that our vaccine may have a significant impact against the Delta variant,” he said. Mene Pangalos, AstraZeneca executive.

Regarding Delta, in addition, the head of the WHO anti-COVID Technical Cell, María Van Kerkhove, pointed out that this variant is already circulating in 92 countries and that now “has the opportunity to be transmitted with the increase in socialization if the relaxation of the measures is done too soon,” according to EFE.

Meanwhile, Kappa would be another sublineage of COVID-19 that also emerged in India and is still considered only of interest, so more in-depth studies are necessary to know its real magnitude, unlike Delta, which together with Alpha, Beta and Gama are considered of concern.

Editor’s Recommendations